blind placebo

Related by string. * Bed Liner . BLIND . BLIN . Blind : blind placebo controlled . Blind Faith . blind eye / placebos . Placebo . Placebos : placebo controlled clinical trials . randomized placebo controlled . blinded placebo controlled * double blind placebo . Randomized Double Blind Placebo . Blind Placebo Controlled Trial . Double Blind Placebo . Blind Placebo Controlled *

Related by context. Frequent words. (Click for all words.) 68 multicenter randomized double 68 blind randomized 67 randomized placebo controlled 66 randomized 65 randomized #:# 65 placebo controlled 64 blind randomized placebo 63 randomized controlled 63 randomized double 63 blind placebo controlled 62 double blind placebo 62 dose escalation 61 prospective randomized 60 multiple ascending dose 60 randomisation 60 placebo controlled trials 60 single ascending dose 59 unblinded 59 dose escalation study 59 multicenter 58 mg BID 58 Phase 2b study 58 randomized clinical 57 label dose escalation 57 mg dose 57 dose escalation trial 57 Randomized 57 peginterferon 56 Phase 1b clinical 56 mcg kg 56 randomized controlled clinical 56 multicenter study 56 plus ribavirin 56 dose regimen 56 phase IIb 55 Secondary endpoints 55 peginterferon alfa 2a 55 Phase Ib 55 Phase 1b 55 Phase IIa 55 Phase 2a clinical 55 randomization 55 phase 2a 55 Phase 2b clinical 55 evaluable patients 55 safety tolerability 55 Phase IIa trial 55 non inferiority 55 prospective cohort 55 citalopram 55 lacosamide 55 sunitinib 54 bosentan 54 monotherapy 54 ADL# 54 titration 54 evaluable 54 FOLFOX 54 adalimumab 54 RG# [001] 54 HbA1c levels 54 composite endpoint 54 dose limiting toxicities 54 Phase IIa clinical 54 rotigotine 54 Phase 2a trial 54 randomly assigned 53 Phase 2b trial 53 randomized controlled trial 53 azacitidine 53 pharmacokinetic 53 pharmacodynamics 53 pramipexole 53 pregabalin 53 mg doses 53 pegylated interferon 53 events AEs 53 relapsing remitting multiple sclerosis 53 metastatic renal cell carcinoma 53 Phase IIb trial 53 tiotropium 53 vicriviroc 53 inactive placebo 52 n = 52 ocular hypertension 52 statistically significant improvement 52 cetrorelix 52 Phase 2b 52 pivotal Phase 52 Phase 2a 52 relapsing remitting MS 52 polysomnography 52 lamotrigine 52 pivotal Phase III 52 TMC# [001] 52 etanercept 52 Phase IIb clinical 52 PRX # 52 COPAXONE R 52 abatacept 52 rosuvastatin

Back to home page